Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   glycine encephalopathy
  

Disease ID 172
Disease glycine encephalopathy
Definition
An autosomal recessive metabolic disorder caused by deficiencies in the mitochondrial GLYCINE cleavage system.
Synonym
disorder of glycine cleavage enzyme complex
encephalopathies, glycine
encephalopathy, glycine
gce
glycine encephalopathies
hyperglycinemia, non-ketotic
hyperglycinemia, nonketotic
hyperglycinemia, nonketotic [disease/finding]
hyperglycinemias, non-ketotic
hyperglycinemias, nonketotic
nkh
nkh - non-ketotic hyperglycinaemia
nkh - non-ketotic hyperglycinemia
non ketotic hyperglycinaemia
non ketotic hyperglycinemia
non-ketotic hyperglycinaemia
non-ketotic hyperglycinemia
non-ketotic hyperglycinemia (disorder)
non-ketotic hyperglycinemias
nonketotic hyperglycinemia
nonketotic hyperglycinemias
Orphanet
OMIM
DOID
ICD10
UMLS
C0751748
MeSH
SNOMED-CT
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:3)
GLDC  |  2731  |  CLINVAR;CTD_human;UNIPROT;GHR
AMT  |  275  |  CLINVAR;CTD_human;UNIPROT;GHR
GCSH  |  2653  |  CLINVAR;CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:3)
275  |  AMT  |  infer
2653  |  GCSH  |  infer
2731  |  GLDC  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:88)
3028  |  HSD17B10  |  DISEASES
440  |  ASNS  |  DISEASES
1738  |  DLD  |  DISEASES
79152  |  FA2H  |  DISEASES
55163  |  PNPO  |  DISEASES
23229  |  ARHGEF9  |  DISEASES
4608  |  MYBPH  |  DISEASES
23314  |  SATB2  |  DISEASES
11019  |  LIAS  |  DISEASES
217  |  ALDH2  |  DISEASES
23417  |  MLYCD  |  DISEASES
5605  |  MAP2K2  |  DISEASES
10000  |  AKT3  |  DISEASES
57575  |  PCDH10  |  DISEASES
2743  |  GLRB  |  DISEASES
6821  |  SUOX  |  DISEASES
3073  |  HEXA  |  DISEASES
5428  |  POLG  |  DISEASES
5373  |  PMM2  |  DISEASES
23126  |  POGZ  |  DISEASES
275  |  AMT  |  DISEASES
84276  |  NICN1  |  DISEASES
80224  |  NUBPL  |  DISEASES
26040  |  SETBP1  |  DISEASES
6326  |  SCN2A  |  DISEASES
8659  |  ALDH4A1  |  DISEASES
1742  |  DLG4  |  DISEASES
9839  |  ZEB2  |  DISEASES
6323  |  SCN1A  |  DISEASES
57215  |  THAP11  |  DISEASES
2752  |  GLUL  |  DISEASES
387787  |  LIPT2  |  DISEASES
48  |  ACO1  |  DISEASES
2653  |  GCSH  |  DISEASES
6888  |  TALDO1  |  DISEASES
348932  |  SLC6A18  |  DISEASES
51218  |  GLRX5  |  DISEASES
84679  |  SLC9A7  |  DISEASES
388962  |  BOLA3  |  DISEASES
2903  |  GRIN2A  |  DISEASES
219541  |  MED19  |  DISEASES
1431  |  CS  |  DISEASES
51601  |  LIPT1  |  DISEASES
875  |  CBS  |  DISEASES
6334  |  SCN8A  |  DISEASES
4948  |  OCA2  |  DISEASES
1644  |  DDC  |  DISEASES
3785  |  KCNQ2  |  DISEASES
55503  |  TRPV6  |  DISEASES
5575  |  PRKAR1B  |  DISEASES
6536  |  SLC6A9  |  DISEASES
2271  |  FH  |  DISEASES
200205  |  IBA57  |  DISEASES
55811  |  ADCY10  |  DISEASES
4942  |  OAT  |  DISEASES
26227  |  PHGDH  |  DISEASES
10479  |  SLC9A6  |  DISEASES
1491  |  CTH  |  DISEASES
1557  |  CYP2C19  |  DISEASES
6834  |  SURF1  |  DISEASES
57526  |  PCDH19  |  DISEASES
6812  |  STXBP1  |  DISEASES
546  |  ATRX  |  DISEASES
2170  |  FABP3  |  DISEASES
3155  |  HMGCL  |  DISEASES
8242  |  KDM5C  |  DISEASES
415  |  ARSE  |  DISEASES
2731  |  GLDC  |  DISEASES
2235  |  FECH  |  DISEASES
2617  |  GARS  |  DISEASES
4099  |  MAG  |  DISEASES
51347  |  TAOK3  |  DISEASES
5091  |  PC  |  DISEASES
152789  |  JAKMIP1  |  DISEASES
501  |  ALDH7A1  |  DISEASES
27247  |  NFU1  |  DISEASES
132158  |  GLYCTK  |  DISEASES
8890  |  EIF2B4  |  DISEASES
3908  |  LAMA2  |  DISEASES
34  |  ACADM  |  DISEASES
2566  |  GABRG2  |  DISEASES
2741  |  GLRA1  |  DISEASES
6513  |  SLC2A1  |  DISEASES
10243  |  GPHN  |  DISEASES
2638  |  GC  |  DISEASES
9152  |  SLC6A5  |  DISEASES
5053  |  PAH  |  DISEASES
2108  |  ETFA  |  DISEASES
Locus(Waiting for update.)
Disease ID 172
Disease glycine encephalopathy
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:13)
HP:0002079  |  Hypoplasia of the corpus callosum
HP:0001254  |  Lethargy
HP:0010851  |  EEG with burst suppression
HP:0012705  |  Abnormal metabolic brain imaging by MRS
HP:0005972  |  Respiratory acidosis
HP:0001250  |  Seizures
HP:0100247  |  Recurrent singultus
HP:0005957  |  Breathing dysregulation
HP:0002033  |  Poor suck
HP:0002353  |  EEG abnormality
HP:0002123  |  Generalized myoclonic seizures
HP:0002154  |  Hyperglycinemia
HP:0011398  |  Central hypotonia
Text Mined Phenotype(Waiting for update.)
Disease ID 172
Disease glycine encephalopathy
Manually Symptom
UMLS  | Name(Total Manually Symptoms:2)
C0596992  |  myelinopathy
C0027765  |  neurologic disorder
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:112)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs11619229010873393275AMTumls:C0751748UNIPROTBiochemical and molecular investigations of patients with nonketotic hyperglycinemia.0.3631813582000AMT349419325CT
rs121964974NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96588417CA
rs121964975NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554716GAA-
rs121964976112865062731GLDCumls:C0751748UNIPROTRecurrent mutations in P- and T-proteins of the glycine cleavage complex and a novel T-protein mutation (N145I): a strategy for the molecular investigation of patients with nonketotic hyperglycinemia (NKH).0.3746017792001GLDC96589230CT,G
rs121964976NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96589230CT,G
rs121964977152364132731GLDCumls:C0751748BeFreeThree of four nonketotic hyperglycinemia patients homozygous for a novel GLDC mutation (A802V) were treated by assisted respiration and/or sodium benzoate with or without ketamine and had transient neonatal or absent symptoms and normal developmental outcome, despite persisting biochemical evidence of nonketotic hyperglycinemia.0.3746017792004GLDC96553420GA
rs121964977NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553420GA
rs121964978NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96645498AG
rs121964979NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96595109GA
rs121964980NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554768CT
rs121964981NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349419042CT
rs121964982NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT;NICN1349422223CT,A
rs121964983NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT;NICN1349422237TC
rs121964984NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349419022CG
rs121964985NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349417892CT
rs121964986NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349419382GA
rs181134220NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349417974CT
rs386833516NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604643-A
rs386833517NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604637GC,A
rs386833518NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604592T-
rs386833519NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96602153GC
rs386833520NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96595100G-
rs386833521NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592982GA
rs386833522NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592966-TTTG
rs386833523NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592933AT
rs386833524NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592870CT
rs386833525NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592224CG
rs386833526NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592180-C
rs386833527NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96588688GC
rs386833528NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96588686TA
rs386833529NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96588629TC
rs386833530NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96645324CG
rs386833531NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96587205GA
rs386833532NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96587159ACCTGGTCATA-
rs386833533NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96587159AC
rs386833534NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96565353CT
rs386833535NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96558680CA
rs386833536NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96558659TC
rs386833537NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96558615GA
rs386833538NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556275CG
rs386833539NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556257GC
rs386833540NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556250GA
rs386833541NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556200GATTAAACCAGGA
rs386833542NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556173CG
rs386833543NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556169G-
rs386833544NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556159AT
rs386833545NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554783TC
rs386833546NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554770AC-
rs386833547NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554726TG
rs386833549NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554703CT,G
rs386833550NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554700CT
rs386833551NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554691GA
rs386833552NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554678GA
rs386833553NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554673CT
rs386833554NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553510CT
rs386833555NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553501TC
rs386833556NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553457GA
rs386833557NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553411CT
rs386833558NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553403T-
rs386833559NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96645255AC
rs386833560NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96550883GA
rs386833561NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96550853AT
rs386833562NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96550851CG
rs386833563NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96645244CT
rs386833564NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96540142AG,C
rs386833565NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96540109GT
rs386833566NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96540077TA
rs386833567NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96540060GA
rs386833568NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96536059CT
rs386833569NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534789CG
rs386833570NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534781GA
rs386833571NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534758AG
rs386833572NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534735-T
rs386833573NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534731TC
rs386833574NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96645472G-
rs386833575NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534707CT
rs386833576NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96620259GC,A
rs386833577NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96620241TA
rs386833578NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96620205TG
rs386833579NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96620197CA
rs386833580NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96610345TC
rs386833581NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96610314CG
rs386833582NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96610267GT
rs386833583NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96610222GA
rs386833583214113533918LAMC2umls:C0751748BeFreeA 9-year-old boy with learning disability and intermittent choreoathetosis during febrile illnesses had elevated plasma glycine level and CSF/plasma glycine ratio (0.044) and a novel homozygous missense mutation (c.605C>T; p.Ala202Val) in the GLDC gene, confirming the diagnosis of NKH.0.0005428842011GLDC96610222GA
rs386833583214113531437CSF2umls:C0751748BeFreeA 9-year-old boy with learning disability and intermittent choreoathetosis during febrile illnesses had elevated plasma glycine level and CSF/plasma glycine ratio (0.044) and a novel homozygous missense mutation (c.605C>T; p.Ala202Val) in the GLDC gene, confirming the diagnosis of NKH.0.0005428842011GLDC96610222GA
rs386833583214113532731GLDCumls:C0751748BeFreeA 9-year-old boy with learning disability and intermittent choreoathetosis during febrile illnesses had elevated plasma glycine level and CSF/plasma glycine ratio (0.044) and a novel homozygous missense mutation (c.605C>T; p.Ala202Val) in the GLDC gene, confirming the diagnosis of NKH.0.3746017792011GLDC96610222GA
rs386833584NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96610192CT,A
rs386833585NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96606599GC,A
rs386833586NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96605199G-
rs386833587NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96605186GA
rs386833588NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96605184CA
rs386833589NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96605145CG
rs386833590NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96605130CA
rs386833591NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604759AC
rs386833592NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604709CT,G,A
rs386833593NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604661GT
rs386833678NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT;NICN1349422214C-
rs386833679NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT;NICN1349422145GA
rs386833680NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT;NICN1349422132GA
rs386833681NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349421573CG
rs386833682NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349420248TA
rs386833683NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349420216TGAGGGCCAAATCTT-
rs386833684NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349420209AG
rs386833685NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349419725G-
rs386833689NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349419282TC
rs386833690NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349417964CT
rs386833691NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349417879CAT-
rs386833692NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349417868GCA
rs386833859NA2653GCSHumls:C0751748CLINVARNA0.243452799NAGCSH1681082964CA
rs772871471NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96587249GC
rs797045082NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349418978CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:3)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0751748leucovorinD0029551958/5/9hyperglycinemia, nonketoticMESH:D020158therapeutic6264089
C0751748glycineD00599856-40-6hyperglycinemia, nonketoticMESH:D020158marker/mechanism16404748
C0751748dextromethorphanD003915125-71-3hyperglycinemia, nonketoticMESH:D020158therapeutic1385627
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)